Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity.
published in: OncoImmunology
date of publication: 2017-04-24
Cites articles 64
Date
Title
Article - wd:Q48170351